GENEGO EXPANDS LICENSE WITH JOHNSON & JOHNSON

GeneGo, Inc. has announced that Johnson & Johnson Pharmaceutical Research & Development, (J&JPRD), a division of Janssen Pharmaceutica N.V., has extended their MetaCore license to now include MetaBase, a database J&JPRD will primarily use for biomarker discovery.

Metabolomics.net (http://www.metabolomics.net/index.aspx?ID=69655)